ArticleAnnals of the rheumatic diseases2023

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.

Thomas Frisell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.